Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Gastric Cancer

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    July 2022
  1. HE D, Chen M, Chang L, Gu J, et al
    De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer.
    Cancer Lett. 2022 Jul 31:215837. doi: 10.1016/j.canlet.2022.215837.
    PubMed     Abstract available


  2. WANG M, Cai W, Yang AJ, Wang CY, et al
    Gastric cancer cell-derived extracellular vesicles disrupt endothelial integrity and promote metastasis.
    Cancer Lett. 2022 Jul 13:215827. doi: 10.1016/j.canlet.2022.215827.
    PubMed     Abstract available


  3. HU F, Peng Y, Chang S, Luo X, et al
    Vimentin binds to a novel tumor suppressor protein, GSPT1-238aa, encoded by circGSPT1 with a selective encoding priority to halt autophagy in gastric carcinoma.
    Cancer Lett. 2022 Jul 12:215826. doi: 10.1016/j.canlet.2022.215826.
    PubMed     Abstract available


    June 2022
  4. ZENG S, Xie X, Xiao YF, Tang B, et al
    Corrigendum to "Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression" [Cancer Lett. 2018 Jan 1;412:179-187].
    Cancer Lett. 2022 Jun 24:215805. doi: 10.1016/j.canlet.2022.215805.
    PubMed    


  5. HONG YH, Aziz N, Park JG, Lee D, et al
    The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer.
    Cancer Lett. 2022;544:215803.
    PubMed     Abstract available


    May 2022
  6. HE J, Hu W, Ouyang Q, Zhang S, et al
    Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer.
    Cancer Lett. 2022 May 30:215764. doi: 10.1016/j.canlet.2022.215764.
    PubMed     Abstract available


    April 2022
  7. LIU X, Lu Y, Xu Y, Hou S, et al
    Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134].
    Cancer Lett. 2022 Apr 29:215695. doi: 10.1016/j.canlet.2022.215695.
    PubMed    


  8. YAMADA H, Takeshima H, Fujiki R, Yamashita S, et al
    ARID1A loss-of-function induces CpG island methylator phenotype.
    Cancer Lett. 2022;532:215587.
    PubMed     Abstract available


  9. CHEN T, Jinlin D, Wang F, Yuan Z, et al
    GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling.
    Cancer Lett. 2022 Apr 26:215692. doi: 10.1016/j.canlet.2022.215692.
    PubMed     Abstract available


    March 2022
  10. ZHANG JY, Du Y, Gong LP, Shao YT, et al
    ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3.
    Cancer Lett. 2022;535:215646.
    PubMed     Abstract available


    February 2022
  11. ZHOU X, Fang D, Liu H, Ou X, et al
    PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer.
    Cancer Lett. 2022 Feb 14:215598. doi: 10.1016/j.canlet.2022.215598.
    PubMed     Abstract available


    December 2021
  12. XU Y, Lu J, Tang Y, Xie W, et al
    PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages.
    Cancer Lett. 2021;529:19-36.
    PubMed     Abstract available


  13. DU Y, Zhang JY, Gong LP, Feng ZY, et al
    Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/VHL/HIF1alpha/VEGFA pathway.
    Cancer Lett. 2021 Dec 1. pii: S0304-3835(21)00605.
    PubMed     Abstract available


    November 2021
  14. MIYAMOTO S, Nagano Y, Miyazaki M, Nagamura Y, et al
    Integrin alpha5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma.
    Cancer Lett. 2021 Nov 12. pii: S0304-3835(21)00575.
    PubMed     Abstract available


  15. LI ZY, Xie Y, Deng M, Zhu L, et al
    c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer.
    Cancer Lett. 2021 Nov 9. pii: S0304-3835(21)00572.
    PubMed     Abstract available


    October 2021
  16. ZHANG H, Ma RR, Zhang G, DongYi, et al
    Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis.
    Cancer Lett. 2021 Oct 6. pii: S0304-3835(21)00503.
    PubMed     Abstract available


    September 2021
  17. DAI W, Liu S, Zhang J, Pei M, et al
    Vorinostat triggers miR-769-5p/3p-mediated suppression of proliferation and induces apoptosis via the STAT3-IGF1R-HDAC3 complex in human gastric cancer.
    Cancer Lett. 2021 Sep 2. pii: S0304-3835(21)00437.
    PubMed     Abstract available


    August 2021
  18. SUGIMOTO A, Okuno T, Miki Y, Tsujio G, et al
    EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells.
    Cancer Lett. 2021 Aug 30. pii: S0304-3835(21)00428.
    PubMed     Abstract available


  19. JIANG L, Chen Y, Min G, Wang J, et al
    Bcl2-associated athanogene 4 promotes the invasion and metastasis of gastric cancer cells by activating the PI3K/AKT/NF-kappaB/ZEB1 axis.
    Cancer Lett. 2021 Aug 19. pii: S0304-3835(21)00409.
    PubMed     Abstract available


    July 2021
  20. LIN DC, Zheng SY, Zhang ZG, Luo JH, et al
    TRPC3 promotes tumorigenesis of gastric cancer via the CNB2/GSK3beta/NFATc2 signaling pathway.
    Cancer Lett. 2021 Jul 23. pii: S0304-3835(21)00370.
    PubMed     Abstract available


    June 2021
  21. KOH V, Chakrabarti J, Torvund M, Steele N, et al
    Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids.
    Cancer Lett. 2021 Jun 11. pii: S0304-3835(21)00292.
    PubMed     Abstract available


  22. CHEN Y, Li Y, Qi C, Zhang C, et al
    Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients.
    Cancer Lett. 2021;517:78-87.
    PubMed     Abstract available


  23. MILIOTIS C, Slack FJ
    miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
    Cancer Lett. 2021 Jun 4. pii: S0304-3835(21)00268.
    PubMed     Abstract available


    December 2020
  24. DAVERN M, Lysaght J
    Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.
    Cancer Lett. 2020;495:89-99.
    PubMed     Abstract available


    October 2020
  25. ZHU S, Khalafi S, Chen Z, Poveda J, et al
    Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.
    Cancer Lett. 2020;491:87-96.
    PubMed     Abstract available


  26. TANG H, Kong Y, Guo J, Tang Y, et al
    Corrigendum to "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22" [Canc. Lett. 340 (1) (Oct 28, 2013) 72-81].
    Cancer Lett. 2020 Oct 5. pii: S0304-3835(20)30356.
    PubMed    


    September 2020
  27. YANG J, Liu Z, Zeng B, Hu G, et al
    Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Cancer Lett. 2020 Sep 23. pii: S0304-3835(20)30486.
    PubMed     Abstract available


  28. MA DH, Li BS, Liu JJ, Xiao YF, et al
    Corrigendum to 'miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway'[Cancer Lett. 2017 Nov 1;408:23-32].
    Cancer Lett. 2020 Sep 22. pii: S0304-3835(20)30470.
    PubMed    


    August 2020
  29. ZENG Y, Ren M, Li Y, Liu Y, et al
    Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway.
    Cancer Lett. 2020 Aug 26. pii: S0304-3835(20)30368.
    PubMed     Abstract available


  30. LIU Y, Zhang X, Zhang Y, Hu Z, et al
    Corrigendum to "Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer"[Canc. Lett. 369 (2015) 58-66].
    Cancer Lett. 2020;494:3-4.
    PubMed    


    July 2020
  31. XIE S, Chang Y, Jin H, Feng Y, et al
    Non-coding RNAs in gastric cancer.
    Cancer Lett. 2020 Jul 23. pii: S0304-3835(20)30352.
    PubMed     Abstract available


    April 2020
  32. WANG J, Wu X, Dai W, Li J, et al
    The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer.
    Cancer Lett. 2020 Apr 8. pii: S0304-3835(20)30159.
    PubMed     Abstract available


    March 2020
  33. WANG Y, Lu JH, Wang F, Wang YN, et al
    Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
    Cancer Lett. 2020;473:74-89.
    PubMed     Abstract available


  34. TAM BY, Chiu K, Chung H, Bossard C, et al
    The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Cancer Lett. 2020;473:186-197.
    PubMed     Abstract available


  35. ZHAO M, Hou Y, Du YE, Yang L, et al
    Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism.
    Cancer Lett. 2020 Mar 3. pii: S0304-3835(20)30109.
    PubMed     Abstract available


    February 2020
  36. PAN H, Pan J, Chen P, Gao J, et al
    Circular RNA circUBA1 promotes gastric cancer proliferation and metastasis by acting as a competitive endogenous RNA through sponging miR-375 and regulating TEAD4.
    Cancer Lett. 2020 Feb 19. pii: S0304-3835(20)30085.
    PubMed     Abstract available


    January 2020
  37. BAROK M, Le Joncour V, Martins A, Isola J, et al
    ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer.
    Cancer Lett. 2020 Jan 2. pii: S0304-3835(19)30659.
    PubMed     Abstract available


    December 2019
  38. LU J, Wang YH, Yoon C, Huang XY, et al
    Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis.
    Cancer Lett. 2019 Dec 4. pii: S0304-3835(19)30602.
    PubMed     Abstract available


    October 2019
  39. TELLI TA, Bregni G, Camera S, Deleporte A, et al
    PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
    Cancer Lett. 2019 Oct 25. pii: S0304-3835(19)30539.
    PubMed     Abstract available


    February 2019
  40. KOEMANS WJ, Chalabi M, van Sandick JW, van Dieren JM, et al
    Beyond the PD-L1 horizon: In search for a good biomarker to predict success of immunotherapy in gastric and esophageal adenocarcinoma.
    Cancer Lett. 2019;442:279-286.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: